Patrice X. Petit | Signal Transduction | Best Researcher Award

Published on by NESIN Awards

Dr. Patrice X. Petit | signal transduction | Best Researcher Award

 Research director | Centre National de la Recherche Scientifique | France

Dr. Patrice X. Petit, Doctor ès Sciences and PhD in Biology, is a Research Director at the French National Centre for Scientific Research (CNRS), where he has served since 1979 and established an internationally recognized career in cell biology. Trained at the Université Pierre et Marie Curie and the Université Denis Diderot (Paris), his work has focused on the molecular mechanisms governing cell death, mitochondrial dynamics, oxidative stress, and their implications in cancer biology, immunology, and toxicology. Over more than four decades, he has developed a broad international scientific presence through extensive teaching and research collaborations across Europe, North America, and Asia, including academic engagements with institutions such as the Chinese Academy of Sciences, Caltech, UT Southwestern, the Beatson Cancer Research Center in Glasgow, the University of Madrid, and multiple leading universities throughout Scandinavia, Germany, and France. His scientific leadership is further reflected in his service as an elected member (2016–2020) of the Scientific Council of the CNRS Institute of Biological Sciences (INSB). Dr. Petit has authored 134 scientific publications, accumulating approximately 12,500 citations and an h-index of 44, demonstrating sustained research influence across several biomedical domains, including contributions to plant biology. He is an active peer reviewer for major journals such as Cancer Research, Journal of Cell Biology, PNAS, Oncogene, and Cell Death and Differentiation, and he has served as a grant reviewer for major funding bodies, including the Austrian Academy of Sciences, the French National Research Agency (ANR), EMBO, the Swiss National Science Foundation, and the Fondation pour la Recherche Médicale. His interdisciplinary background—ranging from a formal qualification in history (Université Paris Diderot, 1979) to a DIU in rare diseases (Université de Strasbourg, 2017)—underscores both scientific depth and broader intellectual engagement. Through his sustained research output, international collaborations, and service to the scientific community, Patrice X. Petit has contributed significantly to advancing fundamental and translational knowledge in cell biology, with measurable societal impact across biomedical research and education.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

Zamzami, N., Marchetti, P., Castedo, M., Decaudin, D., Macho, A., Hirsch, T., … Petit, P. X. (1995). Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. The Journal of Experimental Medicine, 182(2), 367–377.

Zamzami, N., Marchetti, P., Castedo, M., Zanin, C., Vayssière, J. L., Petit, P. X., … Kroemer, G. (1995). Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. The Journal of Experimental Medicine, 181(5), 1661–1672.

Kroemer, G., Petit, P., Zamzami, N., Vayssière, J. L., & Mignotte, B. (1995). The biochemistry of programmed cell death. The FASEB Journal, 9(13), 1277–1287.

Petit, P. X., Lecoeur, H., Zorn, E., Dauguet, C., Mignotte, B., & Gougeon, M. L. (1995). Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. The Journal of Cell Biology, 130(1), 157–167.

Petit, P. X., Susin, S. A., Zamzami, N., Mignotte, B., & Kroemer, G. (1996). Mitochondria and programmed cell death: Back to the future. FEBS Letters, 396(1), 7–13.

Dr. Petit’s work has fundamentally advanced our understanding of mitochondrial biology and programmed cell death, shaping modern concepts of apoptosis, autophagy, and cellular stress responses. His discoveries enabled new biomedical approaches to cancer, immunology, and rare diseases

Hywel Williams | Genomic Medicine | Best Researcher Award

Published on by NESIN Awards

Dr. Hywel Williams | Genomic Medicine | Best Researcher Award

Senior Lecturer | Cardiff University | United Kingdom

Dr. Hywel J. Williams is a distinguished academic and researcher currently serving as a Senior Lecturer in Bioinformatics: Genetic and Genomic Medicine in the Division of Cancer and Genetics, School of Medicine, Cardiff University, since 2019. He holds a Ph.D. in Genetics from Cardiff University (2001–2005), where his research focused on identifying schizophrenia susceptibility genes on chromosome 22 under the supervision of Prof. Sir Michael J. Owen. His earlier academic qualifications include a B.Sc. (Hons) in Genetics from Cardiff University (1994–1996) and an HND in Applied Biology from the University of Wales Institute Cardiff (1992–1994). Dr. Williams also earned recognition as an Associate Fellow of the Higher Education Academy in 2018. With over two decades of research experience, his career spans roles such as Senior Research Associate at UCL’s Great Ormond Street Institute of Child Health (2013–2018), and various research positions at Cardiff University from 1997 to 2012. His work integrates bioinformatics, genomics, and molecular genetics, with a primary focus on rare diseases, psychiatric genetics, and genomic medicine. His key contributions include joint first authorship of the landmark study “The 100,000 Genomes Pilot on Rare Disease Diagnosis in Healthcare” published in the New England Journal of Medicine (2021), and senior authorship in studies enhancing rapid pediatric sequencing and understanding of genetic disorders. Dr. Williams possesses advanced research skills in genomic data analysis, variant interpretation, computational biology, and multi-omic integration, contributing to the clinical translation of genome sequencing technologies. With an outstanding academic record—over 19,000 citations, an h-index of 56, and an i10-index of 101—he is recognized for his influential work in genomic research and data-driven healthcare. His career reflects a commitment to improving diagnostic accuracy and patient care through innovative bioinformatics approaches, making him a key contributor to the global advancement of precision and personalized medicine.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate | LinkedIn

Featured Publications

  1. Purcell, S. M., Wray, N. R., Stone, J. L., Visscher, P. M., O’Donovan, M. C., Sullivan, P. F., Williams, H. J., et al. (2009). Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature, 460(7256), 748–752. https://doi.org/10.1038/nature08185 Cited by: 5,521

  2. Schizophrenia Working Group of the Psychiatric Genomics Consortium. (2011). Genome-wide association study identifies five new schizophrenia loci. Nature Genetics, 43(10), 969–976. https://doi.org/10.1038/ng.940 Cited by: 2,110

  3. Fromer, M., Pocklington, A. J., Kavanagh, D. H., Williams, H. J., Dwyer, S., et al. (2014). De novo mutations in schizophrenia implicate synaptic networks. Nature, 506(7487), 179–184. https://doi.org/10.1038/nature12929 Cited by: 1,920

  4. O’Donovan, M. C., Craddock, N., Norton, N., Williams, H., Peirce, T., Moskvina, V., et al. (2008). Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nature Genetics, 40(9), 1053–1055. https://doi.org/10.1038/ng.201 Cited by: 1,327

  5. 100,000 Genomes Project Pilot Investigators (including Williams, H. J.). (2021). 100,000 genomes pilot on rare-disease diagnosis in health care—preliminary report. New England Journal of Medicine, 385(20), 1868–1880. https://doi.org/10.1056/NEJMoa2035790 Cited by: 657

Daniele Lages | Immunology and Microbiology | Best Researcher Award

Published on by NESIN Awards

Mrs . Daniele Lages | Immunology and Microbiology | Best Researcher Award

Doutoranda at Universidade Federal de Minas Gerais , Brazil

Daniele dos Santos Lages is a dedicated Brazilian researcher specializing in public health, with a focus on epidemiology, particularly related to leprosy (hanseníase). Her work combines academic rigor with social impact, addressing neglected diseases and strengthening primary healthcare systems. She is fluent in Portuguese, English, and Spanish, which allows her to collaborate across international boundaries. Daniele has received multiple academic honors, presented research at notable conferences, and published significant contributions on disease surveillance and public health policy. Her involvement in research groups, notably NEPHANS at UFMG, underlines her leadership in advancing public health research in Brazil. She has also completed various international and national health training programs, demonstrating a commitment to lifelong learning and capacity building. Daniele’s blend of academic achievement, research productivity, and social responsiveness positions her as an influential figure in public health, making her a strong candidate for recognition through research and academic excellence awards.

Professional Profile 

Education🎓

Daniele dos Santos Lages has pursued an outstanding academic path focused on nursing and public health at the Federal University of Minas Gerais (UFMG), one of Brazil’s top universities. She earned her bachelor’s degree in Nursing, followed by a specialization in Family Health (Residência Multiprofissional) from the same institution. She further advanced her academic qualifications by completing a Master’s degree and is currently a doctoral candidate in Nursing with a focus on Public Health at UFMG. Throughout her educational journey, she has consistently focused on public health issues, particularly in disease prevention and control, with a strong emphasis on leprosy. Her academic background is complemented by several national and international certifications in epidemiology, health surveillance, and neglected tropical diseases, many of which are issued by globally recognized bodies like WHO and PAHO. This combination of formal education and specialized training gives her a strong foundation for conducting impactful, evidence-based health research.

Professional Experience📝

Daniele has built a meaningful professional career around research and public health services, with an emphasis on leprosy control and primary healthcare strategies. She is an active member of the NEPHANS research group at UFMG, where she contributes to epidemiological studies, health surveillance analysis, and healthcare delivery systems. Her work includes data-driven policy evaluations and healthcare service assessments focused on vulnerable populations affected by neglected diseases. Daniele has authored and co-authored several academic papers and posters, many of which were presented at national and international conferences, receiving awards for scientific excellence. In addition to her research, she has participated in teaching, public health campaigns, and collaborative projects with health institutions and government agencies. Her hands-on experience with Brazil’s Unified Health System (SUS) has informed her practical understanding of public health challenges. By combining academic insight with field engagement, Daniele bridges the gap between theory and practice, making her contributions highly relevant and applicable.

Research Interest🔎

Daniele dos Santos Lages is deeply committed to advancing research in public health, with her primary focus on the epidemiology of neglected tropical diseases, particularly leprosy (hanseníase). Her academic and professional endeavors revolve around disease surveillance, healthcare accessibility, health equity, and the effectiveness of Brazil’s Unified Health System (SUS). Daniele is particularly interested in the social determinants of health, evaluating how poverty, education, and access to care affect disease prevalence and treatment outcomes. She explores the intersection of clinical practice and public policy to propose practical, evidence-based improvements in primary care. Her research integrates quantitative epidemiological data with qualitative insights from affected populations, aiming to inform public health strategies and reduce disease-related stigma. As a doctoral researcher, she is involved in multidisciplinary investigations that align with global health priorities and the Sustainable Development Goals, particularly those concerning the elimination of neglected diseases and the promotion of universal health coverage.

Award and Honor🏆

Daniele dos Santos Lages has been recognized multiple times for her academic excellence and impactful research in public health. Among her accolades, she received awards for the best oral presentation at national conferences, highlighting her effective communication and the societal relevance of her work. She has also been granted scholarships and research support through prestigious programs like PROBIC/FAPEMIG, affirming the merit of her scientific inquiries. Her participation in highly competitive international training programs hosted by the World Health Organization (WHO) and the Pan American Health Organization (PAHO) further underscores her status as a distinguished emerging scholar. These programs focus on epidemiological intelligence, health surveillance, and strategies to combat neglected tropical diseases. Daniele’s consistent recognition reflects her commitment to scientific rigor, community health, and leadership within Brazil’s healthcare research community. These honors not only validate her contributions but also inspire her continued efforts to advance evidence-based practices in public health and epidemiology.

Research Skill🔬

Daniele dos Santos Lages possesses a robust set of research skills that equip her to address complex public health issues with analytical precision and social sensitivity. Her expertise spans epidemiological data analysis, qualitative and quantitative research design, health indicators assessment, and policy evaluation. She is proficient in statistical software and epidemiological tools used for surveillance and data interpretation, allowing her to derive actionable insights from large health datasets. Daniele also demonstrates strong competencies in scientific writing, grant proposal development, and knowledge translation for both academic and public audiences. She actively applies mixed-method approaches to explore healthcare access, disease distribution, and the effectiveness of Brazil’s health policies. In addition to technical skills, she excels in collaborative research, working across disciplines and institutions to contribute to national and international public health projects. Her fluency in Portuguese, English, and Spanish facilitates international collaboration, making her a versatile and globally relevant public health researcher.

Conclusion💡

Daniele dos Santos Lages exhibits exceptional promise and achievement as a public health researcher, particularly in the domain of leprosy surveillance and primary healthcare systems. Her strong academic background, dedication to neglected diseases, and proactive engagement in capacity-building initiatives mark her as a passionate and purpose-driven professional. Her research is not only scientifically relevant but socially responsive, aligning closely with global health equity goals. Although she would benefit from more diversified research themes and wider international exposure, her foundation is solid and future potential is significant. With continued interdisciplinary collaboration and publication in global platforms, Daniele is well-positioned to make substantial contributions to global public health. Therefore, she is a strong and deserving candidate for the Best Researcher Award, especially within categories that recognize early-career excellence, commitment to social determinants of health, and contributions to underrepresented health issues in vulnerable populations. Her work exemplifies the blend of academic rigor and societal relevance that such awards aim to honor.

Publications Top Noted✍️

  • Title: A baixa escolaridade está associada ao aumento de incapacidades físicas no diagnóstico de hanseníase no Vale do Jequitinhonha
    Authors: D dos Santos Lages, BM Kerr, I de Caux Bueno, ENA Niitsuma, FCF Lana
    Year: 2018
    Citations: 51

  • Title: Spatial analysis of the epidemiological risk of leprosy in the municipalities of Minas Gerais
    Authors: IC Bueno, DS Lages, FCF Lana
    Year: 2023
    Citations: 12

  • Title: Profile of the leprosy endemic in the district of Murrupula, Nampula, Mozambique: A population-based study
    Authors: GC Ribeiro, DS Lages, ATC Lages, VB Souza, A Marega, FCF Lana, …
    Year: 2023
    Citations: 4

  • Title: Consistência do registro dos casos de hanseníase no Sistema de Informação de Agravos de Notificação em Minas Gerais-período: 2017 a 2021
    Authors: GCS Reis, DS Lages, FCF Lana
    Year: 2024
    Citations: 2

  • Title: Avaliação do grau de incapacidade física por hanseníase em Minas Gerais
    Authors: D dos Santos Lages, BM Kerr, I de Caux Bueno, ENA Niitsuma, SL Vidal, …
    Year: 2022
    Citations: 2

  • Title: Spatial, Social and Serological Factors in the Prevalence and Risk of Leprosy in Areas of High Endemicity: An Integrative Review
    Authors: DS Lages, ICL Maciel, SL Vidal, FCF Lana
    Year: 2025
    Citations: Not listed (assumed 0 or pending)

  • Title: Análise da ocorrência de sífilis em gestantes em um município da Região Metropolitana de Belo Horizonte entre 2011 e 2021
    Authors: SL Dias, D dos Santos Lages, ICL Maciel, FCF Lana
    Year: 2025
    Citations: Not listed

  • Title: Correlation and Trends in Primary Health Care and Family Health Strategy Coverage of Leprosy Detection in Minas Gerais
    Authors: DS Lages, ICL Maciel, SL Vidal, FCF Lana
    Year: 2025
    Citations: Not listed

  • Title: An interrupted time series study of the leprosy case detection in Brazil after the COVID-19 pandemic
    Authors: GJB Sousa, DS Lages, PPL Barbosa, MCN Rocha, SA de Sena Neto, …
    Year: 2025
    Citations: Not listed

Nour Abdulameer | High Energy Physics | Best Researcher Award

Published on by NESIN Awards

Dr. Nour Abdulameer | High Energy Physics | Best Researcher Award

Student  at Debrecen university, Hungary

Dr. Nour Jalal Abdulameer is a dedicated and emerging researcher in high-energy physics with a strong academic foundation, including a Ph.D. from the University of Debrecen. Her research contributions span nuclear and particle physics, with active involvement in major international collaborations such as the PHENIX Experiment. She has co-authored several technical notes and analysis reports related to particle collisions and solar events, showcasing her skills in data analysis, detector calibration, and simulation. Dr. Abdulameer has also presented at numerous global conferences and participated in advanced workshops, reflecting her active engagement in the scientific community. In addition to research, she has contributed significantly to teaching physics and medical physics across universities in Iraq and Hungary. Proficient in programming and multilingual, she is well-positioned for international collaboration. With further focus on peer-reviewed publications and leading independent research projects, she holds strong potential as a candidate for the Best Researcher Award.

Professional Profile 

Education🎓

Dr. Nour Jalal Abdulameer has pursued a progressive academic path in the field of physics, beginning with a Bachelor’s degree in Physics Science from Thi-Qar University, Iraq (2011–2015). She advanced her specialization by earning a Master’s degree in Nuclear and Plasma Physics from the same institution (2016–2018), where she developed a strong foundation in theoretical and applied physics. Her academic journey reached its pinnacle with her ongoing Ph.D. studies in High Energy Physics at the University of Debrecen, Hungary (2020–present). Throughout her doctoral program, she has engaged in advanced coursework and hands-on research in experimental particle physics, data acquisition, astrophysics, and detector technology. Her participation in specialized schools such as the CERN School in Korea and the Asia-Europe-Pacific School of High-Energy Physics further enriched her technical knowledge. This strong and diverse educational background has equipped her with the expertise and practical skills essential for cutting-edge research in modern physics.

Professional Experience📝

Dr. Nour Jalal Abdulameer has accumulated diverse professional experience across academia, research, and technical roles. She began her academic career as an Assistant Lecturer in Medical Physics at Al-Ayen University, Iraq (2018–2020), where she taught undergraduate laboratory courses. She later served at Thi-Qar University, instructing seminars in Quantum Mechanics, Electricity, and Nuclear Physics. Since 2020, she has been an Assistant Lecturer at the University of Debrecen, Hungary, contributing to physics education while actively engaging in research. Dr. Abdulameer has been a researcher in the PHENIX Experiment and has worked part-time at the Wigner Research Centre for Physics in Budapest since 2023. Her industry-related experience includes a technical role as a Medical Assistant handling dental X-rays and a Sales Engineer position focusing on technical solutions and customer support. These roles demonstrate her versatility in blending research, teaching, and practical applications of physics, underscoring her capability as a well-rounded physics professional.

Research Interest🔎

Dr. Nour Jalal Abdulameer’s research interests lie primarily in the field of high-energy and nuclear physics, with a strong focus on experimental particle physics. Her work involves analyzing heavy-ion collisions to study fundamental particles and their interactions under extreme conditions, as part of the PHENIX Experiment collaboration. She is particularly interested in topics such as Quantum Chromodynamics (QCD), the Standard Model, direct photon and pion production, and the behavior of matter at high temperatures and densities. Her involvement in detector calibration, data acquisition, and online monitoring reflects a technical proficiency in handling complex experimental setups. Additionally, Dr. Abdulameer has explored solar particle events and their relationship with cosmic phenomena, indicating her multidisciplinary approach to research. Her experience with advanced programming tools like ROOT CERN and her participation in international workshops and scientific schools further support her commitment to advancing knowledge in particle physics through both theoretical insight and experimental precision.

Award and Honor🏆

Dr. Nour Jalal Abdulameer has been recognized for her academic and research excellence through several prestigious awards and honors. She was selected to participate in the highly competitive Asia-Europe-Pacific School of High-Energy Physics (AEPSHEP2022) in South Korea, reflecting her standing in the global physics community. Additionally, she has been invited to present her work at esteemed international conferences and workshops, including the Zimányi Winter School (2022 and 2023) in Hungary, the PHENIX training at Stony Brook University and Brookhaven National Laboratory in the USA, and the Initial Stages 2023 Conference in Copenhagen. These opportunities highlight her active involvement and contributions to the field of high-energy physics. Her continued participation in workshops on scientific programming, detector technologies, and particle physics reflects both her academic recognition and commitment to professional development. These accolades underscore her promise and potential as a leading young researcher in experimental physics and related interdisciplinary domains.

Research Skill🔬

Dr. Nour Jalal Abdulameer possesses a comprehensive set of research skills that make her a proficient and impactful scientist in the field of high-energy physics. She is highly skilled in data analysis, simulation, and detector calibration, with hands-on experience in working with particle detectors and large-scale experimental datasets from heavy-ion collisions. Her technical proficiency includes expertise in programming with C++ and using ROOT CERN for data visualization and statistical analysis, as well as LaTeX for scientific documentation. Dr. Abdulameer is adept at applying general research methodologies, modeling, and simulation techniques in experimental particle physics. Her work on the calibration of EMCal ToF and analysis of π0 and direct photon production demonstrates her deep understanding of experimental procedures and attention to precision. Additionally, her collaborative work with international teams, including contributions to technical and analysis notes, illustrates her ability to work effectively in multidisciplinary environments, managing complex research tasks with clarity and rigor.

Conclusion💡

Dr. Nour Jalal Abdulameer is a highly qualified and promising candidate for the Best Researcher Award, especially considering her strong academic progression, active involvement in global high-energy physics experiments, and interdisciplinary engagement. Her background reflects consistent growth, international collaboration, and technical competence, which aligns with the qualities expected from a top researcher.

Publications Top Noted✍️

“Disentangling Centrality Bias and Final-State Effects in the Production of High-pT Neutral Pions Using Direct Photon in d+Au Collisions at √sNN = 200 GeV”

This publication presents a simultaneous measurement of direct photon and neutral pion production in d+Au collisions at √sNN = 200 GeV, analyzing the effects of centrality bias and final-state interactions. The study finds that for minimum-bias collisions, the nuclear modification factor is consistent with unity, while a suppression is observed in the top 5% of events with the highest activity, suggesting possible final-state effects.

Vibhuti Shah | Medicine and Dentistry | Best Researcher Award

Published on by NESIN Awards

Dr. Vibhuti Shah | Medicine and Dentistry | Best Researcher Award

MD, FRCPC at Mount Sinai Hospital, Canada

Dr. Vibhuti Shah is a distinguished neonatologist, clinical epidemiologist, and professor at the University of Toronto, with over two decades of expertise in pediatric research. She serves as Chair of the Research Ethics Board at Mount Sinai Hospital and has played a pivotal role in advancing neonatal care through her extensive research. Holding multiple prestigious qualifications, including an MSc in Clinical Epidemiology, MRCPCH (UK), and FRCPC (Canada), she has been recognized internationally for her contributions, receiving awards such as the Patil Award (AMEE, UK) and invitations from JAMA’s “Author in the Room” program. Dr. Shah’s leadership in academia and research ethics, combined with her mentorship of future medical professionals, underscores her commitment to improving neonatal outcomes. Her work has significantly impacted clinical guidelines and patient care, making her a strong contender for the Best Researcher Award. Her dedication to research excellence continues to shape advancements in neonatology and pediatrics globally.

Professional Profile

Education

Dr. Vibhuti Shah has an extensive educational background in medicine, pediatrics, and clinical research. She earned her MBBS from the University of Bombay in 1982, followed by a Diploma in Child Health (DCH) in 1986 and an MD in Pediatrics in 1987. Further advancing her expertise, she obtained the prestigious MRCP (UK) in 1994 and MRCPCH (UK) in 1997, signifying her specialization in pediatrics and child health. She later achieved the FRCPC (Paediatrics) from the Royal College of Physicians and Surgeons of Canada in 2005, cementing her reputation in the field. Committed to research excellence, Dr. Shah pursued an MSc in Clinical Epidemiology and Healthcare Research at the University of Toronto in 2007. Her extensive training includes fellowships in neonatology and perinatal medicine in India, the UK, and Canada. This strong academic foundation has enabled her to contribute significantly to neonatal research, ethics, and healthcare advancements.

Professional Experience

Dr. Vibhuti Shah has an extensive professional career spanning clinical practice, research, and academic leadership in neonatology and pediatrics. She is a Professor in the Department of Pediatrics and the Institute of Health Policy, Management, and Evaluation at the University of Toronto and a Staff Neonatologist and Clinical Epidemiologist at Mount Sinai Hospital. She also chairs the Research Ethics Board at Mount Sinai Hospital and Humber River Hospital, overseeing research integrity and compliance. Previously, she served as Interim Co-Chair of the Research Ethics Board and held clinical fellowships in neonatology in Canada, the UK, and India. She has been an Associate Member of the School of Graduate Studies at the University of Toronto since 2008 and has contributed significantly to mentoring and training medical professionals. With decades of experience in research, clinical care, and ethics, Dr. Shah has played a vital role in shaping neonatal healthcare policies and advancing pediatric medicine.

Research Interest

Dr. Vibhuti Shah’s research interests focus on neonatal-perinatal medicine, clinical epidemiology, and healthcare ethics, with a strong emphasis on improving neonatal outcomes through evidence-based interventions. She has conducted extensive research on pain management in neonates, neonatal resuscitation, and perinatal care strategies, contributing to clinical guidelines that enhance patient care. Her work in clinical epidemiology involves evaluating healthcare interventions, systematic reviews, and meta-analyses to improve neonatal and pediatric care practices. As Chair of the Research Ethics Board at Mount Sinai Hospital, she is also deeply engaged in research ethics, ensuring the ethical conduct of clinical trials and healthcare studies. Additionally, Dr. Shah has been involved in health policy research, focusing on optimizing neonatal healthcare delivery. Her contributions, recognized by prestigious international awards, continue to shape neonatal clinical practices and influence medical education, making a significant impact on global pediatric research and patient care.

Award and Honor

Dr. Vibhuti Shah has received numerous prestigious awards and honors in recognition of her contributions to neonatal research, medical education, and clinical epidemiology. Internationally, she was awarded the Patil Award by the Association for Medical Education in Europe (AMEE, UK) for her work in teaching and learning. She was also selected for the Mid-Atlantic Conference on Perinatal Research in both 2005 and 2006, receiving travel awards for her groundbreaking research in neonatology. In 2006, she was honored with the Thomas Jefferson Honorarium and Speakership for her clinical research contributions. Additionally, she was selected by the Journal of the American Medical Association (JAMA) for its “Author in the Room” program, recognizing her impactful research on neonatal pain management. These accolades underscore Dr. Shah’s exceptional leadership, innovation, and commitment to advancing neonatal healthcare, making her a highly respected figure in the global pediatric research community.

Research Skill

Dr. Vibhuti Shah possesses a diverse set of research skills that have significantly contributed to advancements in neonatal-perinatal medicine and clinical epidemiology. She is highly proficient in clinical trial design, systematic reviews, meta-analyses, and evidence-based medicine, ensuring that neonatal healthcare practices are guided by robust scientific evidence. Her expertise in biostatistics and data analysis allows her to critically evaluate healthcare interventions and contribute to policy changes. As Chair of the Research Ethics Board at Mount Sinai Hospital, she has extensive experience in research ethics, protocol development, and regulatory compliance, ensuring the integrity of clinical studies. Dr. Shah is also skilled in grant writing, peer-reviewed publishing, and mentoring young researchers, fostering innovation in pediatric research. Her ability to integrate clinical epidemiology with neonatology has led to impactful findings that have shaped neonatal care guidelines, demonstrating her strong analytical, ethical, and leadership capabilities in research.

Conclusion

Dr. Vibhuti Shah is an exceptionally strong candidate for the Best Researcher Award due to her outstanding contributions to neonatology, clinical epidemiology, and medical ethics research. While she has already earned international recognition, additional emphasis on research impact metrics and global collaboration could make her case even stronger.

Publications Top Noted

  1. Shah VK, Firmal P, Alam A, Ganguly D, Chattopadhyay S. (2020). Overview of immune response during SARS-CoV-2 infection: lessons from the past. Frontiers in Immunology, 11, 1949. https://pubmed.ncbi.nlm.nih.gov/32849654
    Cited by: 548

  2. Firmal P, Shah VK, Chattopadhyay S. (2020). Insight into TLR4-mediated immunomodulation in normal pregnancy and related disorders. Frontiers in Immunology, 11, 807.
    Cited by: 105

  3. Pant R, Firmal P, Shah VK, Alam A, Chattopadhyay S. (2021). Epigenetic regulation of adipogenesis in development of metabolic syndrome. Frontiers in Cell and Developmental Biology, 8, 619888.
    Cited by: 52

  4. Choksi A, Parulekar A, Pant R, Shah VK, Nimma R, Firmal P, Singh S, et al. (2021). Tumor suppressor SMAR1 regulates PKM alternative splicing by HDAC6-mediated deacetylation of PTBP1. Cancer & Metabolism, 9, 1-17.
    Cited by: 23

  5. Alam A, Taye N, Patel S, Thube M, Mullick J, Shah VK, Pant R, et al. (2019). SMAR1 favors immunosurveillance of cancer cells by modulating calnexin and MHC I expression. Neoplasia, 21(10), 945-962.
    Cited by: 19

  6. Firmal P, Shah VK, Pant R, Chattopadhyay S. (2022). RING finger protein TOPORS modulates the expression of tumor suppressor SMAR1 in colorectal cancer via the TLR4‐TRIF pathway. Molecular Oncology, 16(7), 1523-1540.
    Cited by: 6

  7. Pant R, Alam A, Choksi A, Shah VK, Firmal P, Chattopadhyay S. (2021). Chromatin remodeling protein SMAR1 regulates adipogenesis by modulating the expression of PPARγ. Biochimica et Biophysica Acta (BBA) – Molecular and Cell Biology of Lipids.
    Cited by: 3

  8. Sharma A, Garg S, Shah V, Agrawal P, Lohan P. (2015). Basics of design: lessons from walled city of Jaipur.
    Cited by: 2

Ahmet Altay | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by NESIN Awards

Assoc. Prof. Dr. Ahmet Altay | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Erzincan Üniversitesi, Turkey

Dr. Ahmet Altay is an accomplished researcher and academic in the field of chemistry, specializing in biochemistry, medicinal chemistry, and interdisciplinary sciences. With a strong background in natural product chemistry and anticancer drug discovery, he has contributed significantly to the scientific community through his research on antioxidants, cytotoxic agents, and enzyme inhibition. His extensive publication record in high-impact SCI-Expanded journals highlights his expertise in experimental and computational studies. Currently serving as an Associate Professor at Erzincan Binali Yıldırım University, Dr. Altay continues to push the boundaries of chemical and biochemical research, focusing on novel therapeutic compounds and their biological applications.

Professional Profile 

Education

Dr. Ahmet Altay earned his Ph.D. in Biochemistry from Middle East Technical University (METU), Turkey, in 2015. His doctoral research focused on the antioxidant and cytotoxic properties of Salvia fruticosa M., as well as its effects on cytochrome P450 enzymes and antioxidant gene expression in colon cancer cells.

Professional Experience

Dr. Altay has been a faculty member at Erzincan Binali Yıldırım University since 2016. He started as an Assistant Professor (2016-2018), was promoted to Associate Professor in 2020, and has since been actively involved in research and teaching. His work spans multiple disciplines within chemistry and biochemistry, with a strong focus on drug discovery and molecular interactions. His contributions include supervising graduate students, securing research grants, and collaborating on international scientific projects.

Research Interests

Dr. Ahmet Altay’s research interests lie at the intersection of biochemistry, medicinal chemistry, and pharmacology, with a particular focus on drug discovery and natural product chemistry. His work extensively explores the antioxidant, anticancer, and enzyme-inhibitory properties of bioactive compounds derived from medicinal plants. He is also deeply engaged in molecular docking studies to understand drug-receptor interactions at a computational level. Additionally, his research investigates apoptosis mechanisms, oxidative stress-related disorders, and the modulation of key metabolic pathways in cancer and neurodegenerative diseases. By integrating experimental and computational approaches, Dr. Altay aims to develop novel therapeutic agents that can target cancer, microbial infections, and enzyme-related disorders. His interdisciplinary research combines chemical synthesis, molecular modeling, and pharmacological evaluation to provide innovative solutions in biomedical sciences.

Awards and Honors

Dr. Ahmet Altay has received multiple awards and recognitions for his outstanding contributions to scientific research and academia. His excellence in publishing high-impact research has been acknowledged with best paper awards and recognitions from international conferences and scientific organizations. He has been honored with research grants and funding support for his projects on natural product chemistry and drug discovery. As an active academic, he has also received accolades for his contributions to student mentorship and scientific collaboration. His efforts in cancer research and enzyme inhibition studies have been recognized by national and international institutions. Additionally, his role as a peer reviewer and editorial board member in prestigious scientific journals highlights his expertise and influence in the field. These awards and honors underscore his dedication to advancing biomedical and pharmaceutical sciences.

Research Skills

Dr. Ahmet Altay possesses a diverse set of research skills spanning experimental and computational methodologies. His expertise includes the isolation and structural characterization of bioactive natural products using advanced chromatographic and spectroscopic techniques such as HPLC, GC-MS, and NMR. He is highly proficient in molecular docking, molecular dynamics simulations, and in silico drug design to predict ligand-target interactions. His skills in biochemical assays enable the evaluation of antioxidant, antimicrobial, and anticancer activities of synthetic and natural compounds. Additionally, he has extensive experience in enzyme kinetics, apoptosis studies, and gene expression analysis using RT-PCR and Western blot techniques. His interdisciplinary knowledge allows him to integrate synthetic chemistry, pharmacology, and bioinformatics to address complex biomedical challenges. Dr. Altay’s strong analytical skills, coupled with his experience in mentoring and collaboration, make him a leading researcher in his field.

Conclusion

Dr. Ahmet Altay is a strong candidate for the Best Researcher Award due to his high research output, international collaborations, and contributions to anticancer and biochemical research. To enhance his profile further, he could focus on leading large-scale projects, securing more grants, and publishing in top-tier journals. Nonetheless, his achievements make him a compelling nominee for this award.

Publications Top Noted

  • Title: Diffractaic acid exerts anti-cancer effects on hepatocellular carcinoma HepG2 cells by inducing apoptosis and suppressing migration through targeting thioredoxin reductase 1

    • Authors: Emine Karaca Sulukoğlu, Şükran Günaydın, Şeyda Nur Kalın, Ahmet Altay, Harun Budak
    • Year: 2024
    • Citation: Naunyn-Schmiedeberg’s Archives of Pharmacology
    • DOI: 10.1007/s00210-024-02980-5

  • Title: The Combined Effect of Vulpinic Acid and Doxorubicin in Breast Cancer MCF-7 Cells

    • Authors: Esma Kübra Kağan Yeniçeri, Ahmet Altay
    • Year: 2024
    • Citation: Erzincan Üniversitesi Fen Bilimleri Enstitüsü Dergisi
    • DOI: 10.18185/erzifbed.1376859

  • Title: Diffractaic acid exhibits thioredoxin reductase 1 inhibition in lung cancer A549 cells

    • Authors: Şükran Günaydın, Emine Karaca Sulukoğlu, Şeyda Nur Kalın, Ahmet Altay, Harun Budak
    • Year: 2023
    • Citation: Journal of Applied Toxicology
    • DOI: 10.1002/jat.4505

  • Title: Effect of evernic acid on human breast cancer MCF‐7 and MDA‐MB‐453 cell lines via thioredoxin reductase 1: A molecular approach

    • Authors: Şeyda Nur Kalın, Ahmet Altay, Harun Budak
    • Year: 2023
    • Citation: Journal of Applied Toxicology
    • DOI: 10.1002/jat.4451

  • Title: In Vitro Cytotoxic Evaluation of a Silver(I) Complex Including Non-Steroidal Anti-Inflammatory Drug Niflumic Acid and 3-Picoline on Human-Derived Cancer Cell Lines

    • Authors: Sema Çağlar, Ahmet Altay, Bülent Çağlar, Esma Kübra Kağan Yeniçeri, Betül Harurluoğlu
    • Year: 2022
    • Citation: Erzincan Üniversitesi Fen Bilimleri Enstitüsü Dergisi
    • DOI: 10.18185/erzifbed.1130634

  • Title: A Biochemical Approach for Hedysarum candidissimum from Turkey: Screening Phytochemicals, Evaluation of Biological Activities, and Molecular Docking Study

    • Authors: Ahmet Altay, Esma Yeniceri, Parham Taslimi, Tugba Taskin‐Tok, Mustafa Abdullah Yilmaz, Ekrem Koksal
    • Year: 2022
    • Citation: Chemistry & Biodiversity
    • DOI: 10.1002/cbdv.202200348

  • Title: Phytochemical Analysis and Biological Evaluation of Hypericum linarioides Bosse: in Vitro and in Silico Studies

    • Authors: Ahmet Altay, Esma Kübra Kağan Yeniçeri, Parham Taslimi, Tugba Taskin‐Tok, Mustafa Abdullah Yılmaz, Ekrem Köksal
    • Year: 2022
    • Citation: ChemistrySelect
    • DOI: 10.1002/slct.202200039

Lars Blønd | Medicine and Dentistry | Best Researcher Award

Published on by NESIN Awards

Dr. Lars Blønd | Medicine and Dentistry | Best Researcher Award

Senior Surgeon at Senior Surgeon, Denmark

Dr. Lars Blønd is a distinguished orthopedic surgeon and researcher specializing in patellofemoral surgery. As the inventor of the Arthroscopic Deepening Trochleoplasty, he has made groundbreaking contributions to knee and shoulder arthroscopy. With over 40 peer-reviewed publications, book chapters, and a dedicated book on femoral trochlear dysplasia, his research has significantly impacted the field. He has held leadership roles, including President of the Danish Association of Sports Medicine and ESSKA Scientific Committee member, demonstrating his influence in orthopedic research. Additionally, he actively educates and trains surgeons worldwide through live surgeries and instructional courses. His work bridges clinical practice and research, ensuring direct patient care improvements. While expanding his multidisciplinary collaborations could enhance his impact, his dedication to advancing orthopedic surgery and mentoring the next generation of researchers makes him a highly deserving candidate for the Best Researcher Award.

Professional Profile

Education

Dr. Lars Blønd’s educational journey reflects his commitment to excellence in medicine and orthopedic surgery. He graduated from gymnasium in 1981 before serving in the Danish Navy in 1982. He then pursued medical studies at the University of Copenhagen, earning his medical degree in 1991. Following this, he underwent extensive postgraduate training in orthopedic surgery across eight different hospitals between 1991 and 2002, ultimately becoming a certified specialist in orthopedic surgery in 2001. Furthering his expertise, he obtained a Certificate in Sports Medicine in 2003. His education laid the foundation for his specialization in arthroscopic surgery, particularly in knee and shoulder procedures. Throughout his career, Dr. Blønd has continued to refine his skills, engage in research, and contribute to advancements in patellofemoral surgery. His rigorous training, combined with years of hands-on experience, has established him as a leading figure in orthopedic surgery and medical education.

Professional Experience

Dr. Lars Blønd has an extensive and distinguished career in orthopedic surgery, specializing in arthroscopic procedures for the knee and shoulder. Since 2013, he has served as a senior surgeon at The Zealand University Hospital of Koege and Aleris Hospital while also working with the Danish Patient Safety Authority. Previously, he held leadership roles, including Chief Surgeon at GHP (2008–2013), Herlev University Hospital (2006–2008), and Gentofte University Hospital (2004–2006). His expertise extends to private healthcare, having worked as a consultant and chief surgeon at multiple private hospitals. Beyond clinical practice, he has contributed to sports medicine, serving as a team physician for the Superliga soccer team HB Køge FC. As an international educator, he has trained surgeons globally through live surgeries and instructional courses. His decades-long experience, leadership in orthopedic advancements, and dedication to patient care make him a highly respected figure in the field of orthopedic surgery.

Research Interest

Dr. Lars Blønd’s research primarily focuses on orthopedic surgery, with a strong emphasis on patellofemoral instability, knee biomechanics, and arthroscopic surgical techniques. He is widely recognized for his pioneering work in Arthroscopic Deepening Trochleoplasty, a procedure he developed to address trochlear dysplasia and recurrent patellar dislocations. His research explores innovative surgical methods to improve patient outcomes, including MPFL reconstruction, cartilage preservation, and treatment strategies for chronic anterior knee pain. Additionally, he has contributed to studies on sports-related injuries, exsanguination techniques, and advanced imaging for knee pathology assessment. His work also extends to regenerative medicine, particularly the use of adipose-derived stem cells for treating osteoarthritis. Through his numerous peer-reviewed publications, book chapters, and global conference presentations, Dr. Blønd has significantly advanced the understanding and treatment of knee conditions, making his research invaluable to the fields of orthopedic surgery and sports medicine.

Award and Honor

Dr. Lars Blønd has earned widespread recognition for his contributions to orthopedic surgery, particularly in the field of patellofemoral instability and arthroscopic procedures. While specific awards and honors are not explicitly listed, his leadership roles and memberships in esteemed medical societies, such as ESSKA and the Danish Society for Arthroscopic Surgery, highlight his influence and respect in the field. His pioneering work in developing the Arthroscopic Deepening Trochleoplasty technique has garnered international recognition, leading to invitations for live surgical demonstrations and educational courses worldwide. Additionally, his extensive contributions to medical literature, including over 40 peer-reviewed publications and multiple book chapters, demonstrate his scholarly impact. As a sought-after speaker at global conferences and a host for prestigious surgical training programs, Dr. Blønd’s work continues to shape modern orthopedic surgery. His dedication to research, education, and surgical innovation reflects the qualities of an esteemed medical professional worthy of high honors.

Research Skill

Dr. Lars Blønd possesses exceptional research skills, demonstrated by his extensive contributions to orthopedic literature and surgical innovation. With over 40 peer-reviewed publications, multiple book chapters, and a leading role in developing Arthroscopic Deepening Trochleoplasty, he has established himself as a key researcher in patellofemoral instability and knee biomechanics. His ability to conduct high-quality clinical studies, retrospective analyses, and surgical technique evaluations showcases his expertise in evidence-based medicine. Dr. Blønd’s research skills extend to advanced imaging interpretation, biomechanical assessments, and regenerative medicine, particularly in the use of adipose-derived stem cells for osteoarthritis treatment. His involvement in international research collaborations, editorial contributions, and live surgical demonstrations further highlights his analytical and problem-solving abilities. As a frequent speaker at global conferences and an educator in arthroscopic surgery, he integrates research with clinical practice, continuously advancing the field of orthopedic surgery through data-driven insights and innovative surgical approaches.

Conclusion

Dr. Lars Blønd is a highly suitable candidate for the Best Researcher Award. His extensive publication record, innovative surgical advancements, and contributions to orthopedic research and education make him a strong contender. While he could further expand his research scope and collaborations, his impact on patellofemoral surgery and sports medicine is undeniable, making him an exemplary researcher in his field.

Publications Top Noted

  • Exercise performance in elite male and female sailors
    Authors: Larsson, B., Beyer, N., Bay, P., Blønd, L., Aagaard, P., and Kjaer, M.
    Year: 1996
    Citation: Int. J Sports Med. 17: 504-508

  • Patellofemoral pain syndrome in athletes: a 5.7-year retrospective follow-up study of 250 athletes
    Authors: Blønd, L. and Hansen, L.
    Year: 1998
    Citation: Acta Orthop Belg. 64: 393-400

  • Injuries caused by falling soccer goalposts in Denmark
    Authors: Blønd, L. and Hansen, L. B.
    Year: 1999
    Citation: Br. J Sports Med. 33: 110-112

  • Scintigraphic method for evaluation of reductions in local blood volumes in human extremities
    Authors: Blønd, L. and Madsen, J.L.
    Year: 2000
    Citation: Scand J Lab Clin Inv. 60;(5): 333-339

  • Exsanguination of lower limbs before surgery
    Authors: Blønd, L., Kirketerp-Moeller K, Sonne-Holm S, and Madsen J.L.
    Year: 2002
    Citation: Acta Orthop Scand. 73;(1): 89-92

  • Exsanguination of upper limbs before surgery
    Authors: Blønd, L. and Madsen, J.L.
    Year: 2002
    Citation: JBJS (Br). 84;(4):489-491

  • Exsanguination of limbs in elderly before surgery: A comparison with young individuals
    Authors: Blønd, L. and Madsen, J.L.
    Year: 2003
    Citation: Int. Orthop. 27;(2): 114-116

  • Bone marrow perfusion in healthy subjects assessed by scintigraphy after application of a tourniquet
    Authors: Blønd, L. and Madsen, J.L.
    Year: 2003
    Citation: Acta Orthop Scand. 74;(4): 460-464

  • Tranexamic acid reduces blood loss and blood transfusion in primary total hip arthroplasty
    Authors: Husted H., Blønd L., Sonne-Holm S., Holm G., Jacobsen T., Gebuhr P.
    Year: 2003
    Citation: Acta Orthop Scand. 74;(6): 665-669

  • Clinical Consequences of Different Exsanguination Methods in Hand Surgery: A Double-blind Randomised Study
    Authors: Blønd L., Jensen NV., Søe-Nielsen NH.
    Year: 2008
    Citation: Journal of Hand Surgery (European Volume) 33; 475

  • Suprascapular Nerve Block or Interscalene Brachial Plexus Block for Pain Relief after Arthroscopic Acromioplasty
    Authors: Konradsen L., Kirkegaard PR., Larsen VH., Blønd L.
    Year: 2009
    Citation: Ambulatory Surgery 15-1

  • The arthroscopic deepening trochleoplasty
    Authors: Blønd L. and Schöttle P.
    Year: 2010
    Citation: Knee Surg Sports Traumatol Arthrosc 18(4):480-5

  • Development in sports medicine
    Authors: Blønd L.
    Year: 2012
    Citation: Ugeskr Laeger 174(12):783

  • Arthroscopic treatment for snapping scapula: a prospective case series
    Authors: Blønd L., & Rechter S.
    Year: 2014
    Citation: Eur J Orthop Surg & Traumatol 24(2):159-64

  • Combined arthroscopic deepening trochleoplasty and reconstruction of the medial patellofemoral ligament for patients with recurrent patella dislocation and trochlear dysplasia
    Authors: Blønd L., & Haugegaard M.
    Year: 2014
    Citation: Knee Surg Sports Traumatol Arthrosc 22:2484–2490

 

 

Raj Ramesar | Medicine and Dentistry | Best Researcher Award

Published on by NESIN Awards

Prof. Raj Ramesar | Medicine and Dentistry | Best Researcher Award

Director: Research Unit at The University of Cape Town, South Africa

Prof. Raj Ramesar is a distinguished geneticist and researcher specializing in human genetics, genomics, and precision medicine. As Head of the Division of Human Genetics and Director of the MRC Genomics and Precision Medicine Research Unit at the University of Cape Town (UCT), he has made pioneering contributions to understanding the genetic basis of hereditary cancers, particularly familial colorectal cancer. His work has led to advancements in genetic testing, risk assessment, and clinical management, earning international recognition, including the Human Genome Organisation (HUGO) Africa Award and the UCT Vice-Chancellor’s Alan Pifer Award for Research Excellence. Prof. Ramesar has played a key role in developing genomic research infrastructure in Africa, collaborating on global initiatives, supervising numerous PhD theses, and advancing precision medicine applications. His research extends to inherited retinal disorders, contributing to clinical trials for genetic blindness treatments. His leadership continues to shape genomic medicine for public health benefits in Africa and beyond.

Professional Profile 

Education

Prof. Raj Ramesar obtained his academic and professional training in human genetics, laying a strong foundation for his contributions to medical genomics. He earned his Ph.D. in Human Genetics from the University of Cape Town (UCT), where he later became a leading academic and researcher. His postgraduate studies focused on the genetic basis of hereditary cancers and inherited disorders, which positioned him at the forefront of genomic medicine in Africa. Over the years, he has engaged in numerous advanced training programs and international collaborations, enhancing his expertise in precision medicine, genomic research, and bioinformatics. As an educator, he has mentored numerous postgraduate students and played a pivotal role in developing genetic research infrastructure in South Africa. His commitment to education extends beyond the university, as he actively participates in initiatives that promote genetic literacy and capacity-building in Africa. His academic journey reflects a deep commitment to advancing genetic research and education globally.

Professional Experience

Prof. Raj Ramesar is a distinguished geneticist with a career spanning several decades, primarily at the University of Cape Town (UCT). He serves as the Head of the Division of Human Genetics and the Department of Pathology at UCT and its affiliated hospitals.

SAMRC

Prof. Ramesar is also the Director of the South African Medical Research Council’s (SAMRC) Genomic and Precision Medicine Research Unit, where he leads research on the genetic underpinnings of inherited cancers and retinal degenerative disorders.

Institute of Development Management

His work has been instrumental in identifying novel genes and mutations within South African populations, with a recent focus on genetic studies in indigenous African communities. Beyond his research, he contributes to the scientific community by serving on editorial boards of international journals and holding leadership roles, including chairing the board of the Africa Genome Education Institute.

African Scientists

Prof. Ramesar’s professional journey reflects a steadfast commitment to advancing human genetics and improving health outcomes through precision medicine.

Research Interest

Prof. Raj Ramesar’s research interests primarily focus on human genetics, with a strong emphasis on hereditary cancers, inherited disorders, and genomic medicine. His work explores the genetic basis of diseases such as colorectal cancer and retinal dystrophies, aiming to develop early detection strategies and targeted therapies. He is deeply involved in precision medicine, leveraging genomic data to tailor healthcare solutions for diverse populations, particularly in Africa. His research also extends to bioinformatics, gene-environment interactions, and ethical considerations in genetic research. As a leader in African genomics, he is dedicated to addressing health disparities through genetic studies, fostering translational research that bridges the gap between laboratory discoveries and clinical applications. Additionally, he actively contributes to capacity-building initiatives, training researchers and clinicians in genomic methodologies. His work has significant implications for personalized medicine, public health policy, and the integration of genetic research into mainstream healthcare systems.

Award and Honor

Prof. Raj Ramesar, Head of the Division of Human Genetics at the University of Cape Town (UCT), has been honored with several prestigious awards recognizing his significant contributions to human genetics. In 2009, he received the UCT Vice-Chancellor’s Alan Pifer Award for his impactful research.

h3africa.org

In 2015, he was elected to the UCT College of Fellows, acknowledging his exceptional academic achievements.

ResearchGate

The following year, Prof. Ramesar was awarded the inaugural Africa Award by the Human Genome Organisation (HUGO) in recognition of his outstanding contributions to human genetics on the continent.

Health Sciences UCT

More recently, he was nominated for the NSTF-South32 Lifetime Award, further highlighting his enduring impact in the field.

Research Skill

Prof. Raj Ramesar possesses extensive research skills in human genetics, genomic medicine, and molecular biology. His expertise lies in identifying genetic markers associated with inherited diseases, particularly in the African population. He has mastered advanced genomic sequencing techniques, bioinformatics analysis, and molecular diagnostics to uncover genetic predispositions to conditions such as inherited cancers and retinal degenerative disorders. His research involves interdisciplinary collaboration, integrating clinical data with genetic insights to develop precision medicine approaches. Prof. Ramesar is highly skilled in genetic epidemiology, population genetics, and translational research, ensuring that scientific discoveries have practical healthcare applications. His ability to lead large-scale genomic studies, mentor young researchers, and contribute to global genetic research initiatives underscores his scientific acumen. He has also played a pivotal role in establishing genetic research frameworks in South Africa, promoting ethical research practices, and advancing the field of genomic medicine in Africa and beyond.

Conclusion

Dr. Rajkumar Ramesar is highly suitable for the Best Researcher Award. His outstanding contributions to human genetics, leadership in genomic research, and commitment to capacity-building in Africa make him a strong candidate. With his international recognition, innovative research, and dedication to precision medicine, he exemplifies the qualities of an award-winning researcher.

Publications Top Noted

  • Distinct Dysregulated Pathways in Sporadic and Lynch Syndrome‐Associated Colorectal Cancer Offer Insights for Targeted Treatment

    • Authors: May J. Krause, Musalula Sinkala, Raj Ramesar
    • Year: 2025
    • Citation: Krause MJ, Sinkala M, Ramesar R. Distinct Dysregulated Pathways in Sporadic and Lynch Syndrome‐Associated Colorectal Cancer Offer Insights for Targeted Treatment. FEBS Lett. 2025; DOI: 10.1002/1873-3468.70010.

  • Screening of Inherited Retinal Disease Patients in a Low‐Resource Setting Using an Augmented Next‐Generation Sequencing Panel

    • Authors: Nicole Midgley, George Rebello, Lara K. Holtes, Raj Ramesar, Lisa Roberts
    • Year: 2024
    • Citation: Midgley N, Rebello G, Holtes LK, Ramesar R, Roberts L. Screening of Inherited Retinal Disease Patients in a Low‐Resource Setting Using an Augmented Next‐Generation Sequencing Panel. Mol Genet Genomic Med. 2024; DOI: 10.1002/mgg3.70046.

  • Genomic Medicine in the Developing World: Cancer Spectrum, Cumulative Risk and Survival Outcomes for Lynch Syndrome Variant Heterozygotes with Germline Pathogenic Variants in the MLH1 and MSH2 Genes

    • Authors: Lutricia Ndou, Ramadhani Chambuso, Ursula Algar, Adam Boutall, Paul Goldberg, Raj Ramesar
    • Year: 2024
    • Citation: Ndou L, Chambuso R, Algar U, Boutall A, Goldberg P, Ramesar R. Genomic Medicine in the Developing World: Cancer Spectrum, Cumulative Risk and Survival Outcomes for Lynch Syndrome Variant Heterozygotes with Germline Pathogenic Variants in the MLH1 and MSH2 Genes. Biomedicines. 2024;12(12):2906. DOI: 10.3390/biomedicines12122906.

  • Influence of Genetic Polymorphisms on the Age at Cancer Diagnosis in a Homogenous Lynch Syndrome Cohort of Individuals Carrying the MLH1:c.1528C>T South African Founder Variant

    • Authors: Lutricia Ndou, Ramadhani Chambuso, Ursula Algar, Paul Goldberg, Adam Boutall, Raj Ramesar
    • Year: 2024
    • Citation: Ndou L, Chambuso R, Algar U, Goldberg P, Boutall A, Ramesar R. Influence of Genetic Polymorphisms on the Age at Cancer Diagnosis in a Homogenous Lynch Syndrome Cohort of Individuals Carrying the MLH1:c.1528C>T South African Founder Variant. Biomedicines. 2024;12(10):2201. DOI: 10.3390/biomedicines12102201.

  • Human Leukocyte Antigen-Allelic Variations May Influence the Age at Cancer Diagnosis in Lynch Syndrome

    • Authors: Lutricia Ndou, Ramadhani Chambuso, Ziyaad Valley-Omar, George Rebello, Ursula Algar, Paul Goldberg, Adam Boutall, Raj Ramesar
    • Year: 2024
    • Citation: Ndou L, Chambuso R, Valley-Omar Z, Rebello G, Algar U, Goldberg P, Boutall A, Ramesar R. Human Leukocyte Antigen-Allelic Variations May Influence the Age at Cancer Diagnosis in Lynch Syndrome. J Pers Med. 2024;14(6):575. DOI: 10.3390/jpm14060575.

  • Investigating Somatic Variants and Pathways in Mismatch Repair-Deficient (dMMR) Colorectal Carcinoma in South Africa

    • Authors: Aldera AP, van der Westhuizen J, Tsai W, Krause MJ, Yildiz S, Pillay K, Boutall A, Ramesar R
    • Year: 2024
    • Citation: Aldera AP, van der Westhuizen J, Tsai W, Krause MJ, Yildiz S, Pillay K, Boutall A, Ramesar R. Investigating Somatic Variants and Pathways in Mismatch Repair-Deficient (dMMR) Colorectal Carcinoma in South Africa. J Clin Pathol. 2024; DOI: 10.1136/jcp-2024-209526.

  • Towards Uncovering the Role of Incomplete Penetrance in Maculopathies through Sequencing of 105 Disease-Associated Genes

    • Authors: Hitti-Malin RJ, Panneman DM, Corradi Z, Boonen EGM, Astuti G, Dhaenens CM, Stöhr H, Weber BHF, Sharon D, Banin E, Raj Ramesar, et al.
    • Year: 2024
    • Citation: Hitti-Malin RJ, Panneman DM, Corradi Z, Boonen EGM, Astuti G, Dhaenens CM, Stöhr H, Weber BHF, Sharon D, Banin E, Ramesar R, et al. Towards Uncovering the Role of Incomplete Penetrance in Maculopathies through Sequencing of 105 Disease-Associated Genes. Biomolecules. 2024;14(3):367. DOI: 10.3390/biom14030367.

  • Human Leukocyte Antigen-Allelic Variations May Influence the Age at Cancer Diagnosis in Lynch Syndrome

    • Authors: Lutricia Ndou, Ramadhani Chambuso, Ziyaad Valley-Omar, George Rebello, Ursula Algar, Paul Goldberg, Adam Boutall, Raj Ramesar
    • Year: 2024
    • Citation: Ndou L, Chambuso R, Valley-O

Heshmatollah Yavari | Physics and Astronomy | Best Researcher Award

Published on by NESIN Awards

Prof. Heshmatollah Yavari | Physics and Astronomy | Best Researcher Award

Prof at Uiversity of Isfaha, Iran

Professor Heshmatollah Yavari is a distinguished academic in the field of theoretical physics, specializing in superconductivity, superfluidity, and strongly correlated systems. He has made significant contributions to the study of Bose-Einstein condensation, ultracold atomic gases, and topological insulators. His research interests extend to optical lattices, granular electronic systems, neutron stars, and the exploration of Majorana fermions. Professor Yavari’s teaching experience spans several advanced topics in physics, including quantum mechanics, many-body physics, and quantum field theory. His publications reflect a broad range of contributions to the understanding of thermal conductivity, viscosity, and magnetic properties in superfluid and superconducting systems, among other topics.

Professional Profile 

Education

Professor Yavari’s academic journey began with a BSc in Physics from the University of Tabriz, followed by an MSc from the University of Isfahan. He then pursued a PhD in Theoretical Physics at the University of Isfahan, where his research focused on the temperature dependence of transport and magnetic coefficients in superfluid and superconductor systems. His academic training laid the foundation for his extensive contributions to the study of condensed matter physics, leading him to a prominent role in both theoretical research and teaching.

Professional Experience

Professor Yavari has held various academic positions at the University of Isfahan. He began his career as an Assistant Professor in 2005 and was promoted to Associate Professor in 2010. In 2016, he was appointed as a Professor in the Department of Physics, where he continues to lead groundbreaking research. Throughout his career, he has actively engaged in the development of advanced courses in quantum mechanics, statistical mechanics, and condensed matter physics, contributing to the education and mentorship of numerous students in the field of physics. His professional experience extends to leadership roles in scientific research and publications, further solidifying his reputation as a leading figure in theoretical physics.

Research Interests

Professor Heshmatollah Yavari’s research interests lie at the intersection of condensed matter physics and quantum mechanics. He is particularly focused on superconductivity and superfluidity, with an emphasis on understanding the fundamental properties and behaviors of quantum systems at low temperatures. His work explores Bose-Einstein condensation, strongly correlated systems, and the phenomena of topological insulators and superconductors. Additionally, Professor Yavari investigates the behavior of ultracold atomic gases in optical lattices and the exotic properties of Majorana fermions, which have implications for quantum computing and high-energy physics. He is also interested in the thermal and transport properties of superfluid systems, neutron stars, and granular electronic systems. His theoretical research contributes to advancing the understanding of quantum matter and opens new avenues in both fundamental science and applied physics.

Awards and Honors

Professor Heshmatollah Yavari has received significant recognition for his contributions to theoretical physics, particularly in the fields of superconductivity and superfluidity. His research has been widely published in international journals, highlighting his influence and expertise in condensed matter physics. Although specific awards and honors are not mentioned, the continuous progression of his academic career, from Assistant Professor to Professor at the University of Isfahan, reflects his dedication and the respect he has earned within the scientific community. Additionally, his long-standing role as a mentor and educator in various advanced physics courses demonstrates his influence in shaping future generations of physicists. His work remains integral to the development of new theoretical models and experimental investigations in quantum physics.

Publications Top Noted

  • Effects of Rashba and Dresselhaus spin-orbit couplings on the critical temperature and paramagnetic limiting field of superconductors with broken inversion symmetry
    • Authors: Yavari, H., Tayebantayeba, M.
    • Year: 2024
    • Citations: 0
  • Impurity and hybridization effects on the symmetry classification and magnetic response function of a two-band superconductor with interband pairing order
    • Authors: Renani, F.A., Yavari, H.
    • Year: 2024
    • Citations: 0
  • Three-body and Coulomb interactions in a quasi-two-dimensional dipolar Bose-condensed gas
    • Authors: Moniri, S.M., Yavari, H., Darsheshdar, E.
    • Year: 2022
    • Citations: 2
  • Effects of hybridization and spin–orbit coupling to induce odd-frequency pairing in two-band superconductors
    • Authors: Tamadonpour, M., Yavari, H.
    • Year: 2021
    • Citations: 2
  • Shear viscosity in the strong interaction regime of a p-wave superfluid Fermi gas
    • Authors: Moniri, S.M., Yavari, H., Darsheshdar, E.
    • Year: 2021
    • Citations: 0
  • Anomalous viscosity of a chiral two-orbital superconductor in tight-binding model
    • Authors: Yazdani-Hamid, M., Yavari, H.
    • Year: 2021
    • Citations: 0
  • Progress in the development and construction of high temperature superconducting magnets
    • Authors: Yavari, H.
    • Year: 2020
    • Citations: 0
  • Effects of Thermally Induced Roton-Like Excitation on the Superfluid Density of a Quasi-2D Dipolar Bose Condensed Gas
    • Authors: Yavari, H., Forouharmanesh, F.
    • Year: 2020
    • Citations: 0
  • Effect of long-range 1/ r interaction on thermal and quantum depletion of a dipolar quasi-two-dimensional Bose gas
    • Authors: Tamaddonpur, M., Yavari, H., Saeidi, Z.
    • Year: 2019
    • Citations: 2
  • Effect of long-range 1/r interaction on thermal and quantum depletion of a dipolar quasi-two-dimensional Bose gas
    • Authors: Tamaddonpur, M., Yavari, H., Saeidi, Z.
    • Year: 2019
    • Citations: 0